156 results
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
., a Delaware corporation (“EyeGate”), and Eric J. Daniels, MD, MBA (the “Employee”).
WHEREAS, the Employer desires to employ the Employee … and the Employee desires to be employed by the Employer, upon and subject to the terms set forth in this Agreement;
NOW, THEREFORE, in consideration
8-K
EX-10.2
KPRX
Kiora Pharmaceuticals Inc
3 Dec 19
Departure of Directors or Certain Officers
6:55am
From (the “Employee”), as of November 26, 2019. Capitalized terms used but not defined in this Amendment shall have the meanings given to such terms … in the Agreement.
WHEREAS, the Employer and the Employee entered into that certain Third Amended and Restated Employment Agreement, dated as of November
8-K
EX-10.3
KPRX
Kiora Pharmaceuticals Inc
1 Feb 21
Departure of Directors or Certain Officers
6:55am
(the “Employer”), and Stephen From the “Employee”).
WHEREAS, the Employer and the Employee entered into an Employment Agreement, dated as of June 24 … , 2005 (the “Original Agreement”);
WHEREAS, the Employer and the Employee amended and restated the Original Agreement by entering into an Amended
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
26 Jul 21
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
4:18pm
”), is made by and between EyeGate Pharmaceuticals, Inc., a Delaware corporation (the “Employer”), and Brian M. Strem, Ph.D. (the “Employee”).
WHEREAS … , the Employer desires to employ the Employee and the Employee desires to be employed by the Employer, upon and subject to the terms set forth
8-K
EX-10.1
ko52t8pa6zge
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.1
ghp7v dqz1ano3
24 Mar 20
Departure of Directors or Certain Officers
4:15pm
DRS/A
EX-10.3
xvfvyg
8 Jul 14
Draft registration statement (amended)
12:00am
DEFA14A
y4my o3h3
3 Jul 18
Additional proxy soliciting materials
4:15pm
8-K
EX-10.1
tinuy 5mhvs739nmef9
1 Feb 22
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
6:45am
8-K
EX-10.1
p88fvi6e86d8bhjalx4g
3 Dec 19
Departure of Directors or Certain Officers
6:55am
DRS/A
EX-10.2
wq91hu aih1ic3dfn
8 Jul 14
Draft registration statement (amended)
12:00am
8-K
EX-10.2
va5fyz
1 Feb 21
Departure of Directors or Certain Officers
6:55am
S-8
3eu y9swc
20 Feb 15
Registration of securities for employees
12:00am
8-K
9ugep
3 Dec 19
Departure of Directors or Certain Officers
6:55am